CureBay closed its Series B round to boost its technology, extend its reach and add staff.
CureBay began in 2021 in Odisha as a platform to link patients in smaller towns with basic health services. The founders built over 150 eClinics across Odisha and Chhattisgarh and trained more than 1,000 Swasthya Mitras to help with consultations, diagnostics, pharmacy orders and referrals for higher-level care. Their preventive health programme grew to 90,000 active members, who return each year at rates above 60 per cent.
In its recent Series B round, CureBay raised $21 million with Bertelsmann India Investments as lead investor. Elevar Equity and British International Investment joined in. The company will use the funds to strengthen its proprietary tech stack, enter Jharkhand, Bihar, Uttar Pradesh and Madhya Pradesh, and hire teams to manage its next growth phase.
Priyadarshi Mohapatra, Founder and CEO of CureBay, said, “At CureBay, we are a mission-driven team focused on transforming public health outcomes for every Indian. This is not just a fundraiser—it’s a mandate to build India’s trust infrastructure for rural health. With an active network of 150+ eClinics and 1,000+ Swasthya Mitras, we are solving for Bharat, where a large part of the population still lacks access to dependable care. The capital will help us scale technology, talent, and reach to bring dignified, affordable healthcare to the last mile. CureBay’s model is deeply aligned with national priorities like Ayushman Bharat and the Digital Health Mission, and we are proud to be a tech-enabled partner in public health delivery. This is not just a startup getting funded—it’s a public health movement getting backed.”
Bertelsmann India Investments is the investment arm of a media and services group. Pankaj Makkar, its Managing Director, said, “We’re excited to partner with CureBay as it builds a differentiated, ecosystem-driven approach to rural healthcare in India. While most rural solutions remain fragmented, CureBay uniquely delivers the full continuum of care under one platform —seamlessly integrating consultations, diagnostics, pharmacy access, and surgeries through its tech-enabled eClinics and robust partner network. This investment reflects Bertelsmann India’s strong commitment to supporting mission-driven companies that are transforming Bharat, with CureBay making quality healthcare both accessible and affordable for rural communities.”
Elevar Equity, which first backed CureBay in 2022, also took part in the round. Jyotsna Krishnan, Managing Partner, said, “CureBay has demonstrated that a thoughtfully constructed business model can deliver robust unit economics and contribution margins. On the one hand, they leverage cutting-edge technology and AI, but more importantly, they blend into the local ecosystem to build critical trust on the ground in rural markets through a unique distribution set-up. Entrepreneurial households in India are keen to pay for quality healthcare, and this is a massive underserved segment. We are glad Elevar’s original investment thesis in 2022 played out well. This round is an important milestone for the company as they continue to build scale in a disciplined manner.”
CureBay’s platform links AI, machine learning and IoT diagnostics to track early warning signs, personalise care paths and streamline workflows. The team reports operational profits in its Balasore and Puri service areas.
The new funds mark a step in CureBay’s plan to deliver integrated healthcare in line with national schemes and global health goals. By adding more states, boosting its tech and growing its workforce, the company aims to reach thousands more people who live beyond the reach of conventional clinics.
